Last reviewed · How we verify
NCT03501017
The Effect of Physical Activity on Decreasing Risk Level
NA trial testing physical activity program in CVD Risk in 22 participants. Completed in 20 December 2016.
25 October 2016
Quick facts
| Lead sponsor | Akdeniz University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 22 |
| Start date | 20 June 2016 |
| Primary completion | 25 October 2016 |
| Estimated completion | 20 December 2016 |
Drugs / interventions tested
- physical activity program
- Routine Practice
Conditions studied
- CVD Risk — all drugs for CVD Risk →
- Physical Activity — all drugs for Physical Activity →
- Nurse's Role — all drugs for Nurse's Role →
- Risk Reduction — all drugs for Risk Reduction →
Sponsor
Akdeniz University
Who can join
Adults 40 to 65, any sex, with CVD Risk or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: The aim of the first part of this study with two stages is to determine prevalence of CVD risk and the associated variables in individuals aged 40-65 years registered in a Family Health Center (FHC) in city center of Antalya; the aim of the second one is to evaluate the effect of intervention to increase physical activity in individuals with moderate risk of CVD on decreasing the risk level. Methods: Stage 1 and Stage 2 were conducted as cross-sectional and Randomized Controlled Experimental Trial, respectively. In the first stage the CVD risk level was calculated using the HeartScore. In the second stage, 11 individuals with moderate CVD risk (2-\<5%) found in the intervention group participated into a 12-week physical activity program (a moderate walk outdoor, with group 5 days in a week, each lasting for 40 minutes) guided by nurse. CVD brochure and physical activity guide was distributed to 11 individuals in control group within the scope of routine practice of FHCs.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of a nurse-led physical activity intervention to decrease cardiovascular disease risk in middle-aged adults: A pilot randomized controlled study.
Dağistan Akgöz A, Gözüm S. · · 2020 · cited 5× · PMID 32950115 · DOI 10.1016/j.jvn.2020.05.002
Verify or expand the search:
- PubMed search for NCT03501017
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of physical activity program
Trials testing the same drug.
- NCT07199400 — Using a Technology Assisted Physical Activity Program to Improve Muscle Strength, Joint Mobility, Standing Time,Self-eff · NA · terminated
- NCT04647682 — Physical Activity Program Implementation in Hospitalized Positive COVID-19 Older Adults · completed
- NCT04107948 — Efficiency of an Optimized Care Organization for Fibromyalgia Patients. The FIMOUV 2 Study · NA · recruiting
- NCT03736733 — Relevance of an Adapted and Supervised Physical Activity Program in Fibromyalgia Patients. The FIMOUV 1 Study. · NA · completed
Other Akdeniz University trials
Trials by the same sponsor.
- NCT07581132 — Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients · NA · not yet recruiting
- NCT07469345 — Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men · enrolling by invitation
- NCT07507279 — Technology-based Hand Rehabilitation in Older People · NA · not yet recruiting
- NCT07437924 — Bruxism and Pelvic Floor Dysfunction in Young Women · enrolling by invitation
- NCT07497308 — GDF-15 and Early Outcomes After LVAD Implantation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03501017 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Akdeniz University
- Last refreshed: 18 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03501017.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing